25Q1 环比改善，看好全年业绩修复 ——乐普医疗 2024 年报&2025 年一季报点评 核心观点 盈利预测与投资建议 ⚫ 根据 24 年报及 25 年一季报，我们下调收入及毛利率预测，我们预测公司 2025-2027 年 EPS 分别为 0.54/0.61/0.67 元（原预测 25-26 年 EPS 为 0.75、0.90 元）。根据可 比公司 2025 年平均估值，给予公司 2025 年 23 倍市盈率，对应目标价为 12.42 元， 维持给予"买入"评级。 风险提示 ⚫ 研发进展和新产品商业化不及预期；集采或者市场竞争加剧带来的冲击；大额计提 减值风险。 公司主要财务信息 | | 2023A | 2024A | 2025E | 2026E | 2027E | | --- | --- | --- | --- | --- | --- | | 营业收入(百万元) | 7,980 | 6,103 | 6,835 | 7,378 | 7,968 | | 同比增长 (%) | -24.8% | -23.5% | 12.0% | 7.9% | 8.0% | | 营业利润(百万元) | 1,547 | 253 | ...

业绩环比修复，海内外市场同步拓展 ——海泰新光 2024 年报&2025 年一季报点评 核心观点 盈利预测与投资建议 ⚫ 根据 2024 年报及 2025 年一季报，我们下调收入、毛利率假设，调整 2025-27 年每 股收益预测分别为 1.51/1.79/2.23（原预测 25-26 年为 2.09/2.58）元，根据可比公 司给予 25 年 30 倍 PE，对应的目标价为 45.30 元，维持"买入"评级。 风险提示 大客户依赖风险、地缘政治风险、国内市场拓展不及预期风险、下游需求波动风险 等。 公司主要财务信息 | | 2023A | 2024A | 2025E | 2026E | 2027E | | --- | --- | --- | --- | --- | --- | | 营业收入(百万元) | 471 | 443 | 565 | 691 | 868 | | 同比增长 (%) | -1.3% | -5.9% | 27.5% | 22.4% | 25.6% | | 营业利润(百万元) | 161 | 153 | 206 | 241 | 302 | | 同比增长 (%) | -22.0% | -5.0% ...

25Q1 环比改善，看好全年业绩修复 ——乐普医疗 2024 年报&2025 年一季报点评 核心观点 盈利预测与投资建议 伍云飞 wuyunfei1@orientsec.com.cn 执业证书编号：S0860524020001 香港证监会牌照：BRX199 ⚫ 根据 24 年报及 25 年一季报，我们下调收入及毛利率预测，我们预测公司 2025-2027 年 EPS 分别为 0.54/0.61/0.67 元（原预测 25-26 年 EPS 为 0.75、0.90 元）。根据可 比公司 2025 年平均估值，给予公司 2025 年 23 倍市盈率，对应目标价为 12.42 元， 维持给予"买入"评级。 风险提示 ⚫ 研发进展和新产品商业化不及预期；集采或者市场竞争加剧带来的冲击；大额计提 减值风险。 公司主要财务信息 | | 2023A | 2024A | 2025E | 2026E | 2027E | | --- | --- | --- | --- | --- | --- | | 营业收入(百万元) | 7,980 | 6,103 | 6,835 | 7,378 | 7,968 | | 同比增长 (%) | ...

Investment Rating - The report maintains a "Buy" rating with a target price of HKD 23.25 [3][7] Core Views - The company reported a revenue of CNY 36.22 billion for 2024, representing a year-on-year growth of 9%. However, the net profit attributable to the parent company decreased by 41% to CNY 1.15 billion, while the core net profit fell by 5% to CNY 2.23 billion [2][3][7] - The company's cyclical business showed steady growth, with a revenue of CNY 30.79 billion from cyclical operations, marking a 16% increase year-on-year, which now constitutes 85% of total revenue [7] - The report highlights a significant decline in the gross margin of developer-related businesses, which has dropped to 0%, indicating a potential bottoming out of core net profit [7] Financial Summary - For 2024, the company achieved a revenue of CNY 36.22 billion, with a year-on-year growth of 9.2%. The operating profit was CNY 1.70 billion, down 36.2% from the previous year. The net profit attributable to the parent company was CNY 1.15 billion, a decrease of 41.2% [4][9] - The earnings per share (EPS) for 2024 is projected at CNY 0.98, with future estimates of CNY 1.54, CNY 1.90, and CNY 2.10 for 2025, 2026, and 2027 respectively [4][9] - The gross margin is expected to decline to 13% in 2024, with a slight recovery projected in subsequent years [4][9] Business Segments - The community space, commercial city services, and technology segments generated revenues of CNY 20.9 billion, CNY 12.3 billion, and CNY 3.0 billion respectively, with year-on-year growth rates of 11.5%, 5.4%, and 8.6% [7] - The company has successfully reduced its reliance on related party transactions, with the proportion of revenue from related parties decreasing by 4 percentage points to 9.5% [7] Market Comparison - The report provides a comparison of the company's valuation metrics against peers, indicating an adjusted average PE of 14x for comparable companies in 2025 [3][8]

业绩短期承压，看好中长期成长 ——泰恩康 24 年报&25 年一季报点评 核心观点 盈利预测与投资建议 ⚫ 根据 24 年报，我们下调营业收入预测，预测公司 2025-2027 年每股收益分别为 0.33/0.61/1.01 元（原 2025-2026 年预测为 0.39/0.62 元），根据可比公司，给予公 司 2025 年 69 倍市盈率，对应目标价为 22.77 元，维持"增持"评级。 风险提示 研发进展不及预期风险；新产品放量低预期风险；市场竞争加剧风险；毛利率提升不及 预期风险。 公司主要财务信息 | | 2023A | 2024A | 2025E | 2026E | 2027E | | --- | --- | --- | --- | --- | --- | | 营业收入(百万元) | 761 | 721 | 894 | 1,152 | 1,520 | | 同比增长 (%) | -2.9% | -5.2% | 24.0% | 28.8% | 31.9% | | 营业利润(百万元) | 191 | 109 | 179 | 325 | 530 | | 同比增长 (%) | -8.7% | -43.1% ...

业绩环比修复，海内外市场同步拓展 ——海泰新光 2024 年报&2025 年一季报点评 风险提示 大客户依赖风险、地缘政治风险、国内市场拓展不及预期风险、下游需求波动风险 等。 公司主要财务信息 | | 2023A | 2024A | 2025E | 2026E | 2027E | | --- | --- | --- | --- | --- | --- | | 营业收入(百万元) | 471 | 443 | 565 | 691 | 868 | | 同比增长 (%) | -1.3% | -5.9% | 27.5% | 22.4% | 25.6% | | 营业利润(百万元) | 161 | 153 | 206 | 241 | 302 | | 同比增长 (%) | -22.0% | -5.0% | 34.7% | 17.2% | 25.3% | | 归属母公司净利润(百万元) | 146 | 135 | 183 | 216 | 269 | | 同比增长 (%) | -20.2% | -7.1% | 34.9% | 18.1% | 24.8% | | 每股收益（元） | 1.21 | 1.12 | 1.51 | 1. ...

业绩短期承压，看好中长期成长 ——泰恩康 24 年报&25 年一季报点评 核心观点 盈利预测与投资建议 ⚫ 根据 24 年报，我们下调营业收入预测，预测公司 2025-2027 年每股收益分别为 0.33/0.61/1.01 元（原 2025-2026 年预测为 0.39/0.62 元），根据可比公司，给予公 司 2025 年 69 倍市盈率，对应目标价为 22.77 元，维持"增持"评级。 风险提示 研发进展不及预期风险；新产品放量低预期风险；市场竞争加剧风险；毛利率提升不及 预期风险。 公司主要财务信息 | | 2023A | 2024A | 2025E | 2026E | 2027E | | --- | --- | --- | --- | --- | --- | | 营业收入(百万元) | 761 | 721 | 894 | 1,152 | 1,520 | | 同比增长 (%) | -2.9% | -5.2% | 24.0% | 28.8% | 31.9% | | 营业利润(百万元) | 191 | 109 | 179 | 325 | 530 | | 同比增长 (%) | -8.7% | -43.1% ...

业绩短期承压，看好中长期成长 ——泰恩康 24 年报&25 年一季报点评 核心观点 盈利预测与投资建议 ⚫ 根据 24 年报，我们下调营业收入预测，预测公司 2025-2027 年每股收益分别为 0.33/0.61/1.01 元（原 2025-2026 年预测为 0.39/0.62 元），根据可比公司，给予公 司 2025 年 69 倍市盈率，对应目标价为 22.77 元，维持"增持"评级。 风险提示 研发进展不及预期风险；新产品放量低预期风险；市场竞争加剧风险；毛利率提升不及 预期风险。 公司主要财务信息 | | 2023A | 2024A | 2025E | 2026E | 2027E | | --- | --- | --- | --- | --- | --- | | 营业收入(百万元) | 761 | 721 | 894 | 1,152 | 1,520 | | 同比增长 (%) | -2.9% | -5.2% | 24.0% | 28.8% | 31.9% | | 营业利润(百万元) | 191 | 109 | 179 | 325 | 530 | | 同比增长 (%) | -8.7% | -43.1% ...

Investment Rating - The report maintains a "Buy" rating for the company, with a target price of 47.79 CNY, based on a 27x PE for 2025 [2][4]. Core Views - The company reported Q1 2025 revenue of 4.839 billion CNY, a year-on-year increase of 20.56%, but a net profit attributable to shareholders of 640 million CNY, down 14.78% [1][8]. - The decline in profitability is attributed to a lower proportion of military products, changes in product structure, and rising raw material costs, leading to a gross margin decrease to 28.44% (down 7.12 percentage points) and a net margin decrease to 13.91% (down 5.88 percentage points) [8]. - The company plans to repurchase shares worth between 150 million and 300 million CNY, representing 0.14%-0.28% of the total shares, to enhance investor confidence and internal motivation [8]. - The defense sector is expected to recover, and new industries such as civil aviation and satellite internet present growth opportunities, indicating potential for a return to high-quality growth [8]. Financial Information Summary - Revenue projections for 2025-2027 are 23.778 billion CNY, 27.536 billion CNY, and 31.978 billion CNY, respectively, with expected growth rates of 14.9%, 15.8%, and 16.1% [3]. - The net profit attributable to shareholders is projected to grow from 3.740 billion CNY in 2025 to 5.101 billion CNY in 2027, with growth rates of 11.5% and 17.5% [3]. - The company’s gross margin is expected to stabilize around 36.2% from 2025 to 2027, while the net margin is projected to be around 15.7% to 16.0% [3].

Investment Rating - The investment rating for Jiangsu Bank is "Buy (Maintain)" [8] Core Views - The core revenue has significantly improved, with a decrease in the non-performing loan ratio on a quarter-on-quarter basis [2] - The bank's performance growth has exceeded expectations, with notable improvements in net interest income and fee income growth [8] - The bank's total assets and loan amounts have shown strong growth, indicating a favorable lending environment [8] - The asset quality is stabilizing, with a slight decrease in the non-performing loan ratio and a robust provision coverage ratio [8] Financial Performance Summary - For 2023A, the operating income is projected at 74,293 million yuan, with a year-on-year growth of 5.3% [4] - The net profit attributable to the parent company is expected to reach 28,750 million yuan in 2023A, reflecting a year-on-year increase of 13.3% [4] - The earnings per share (EPS) for 2023A is estimated at 1.52 yuan [4] - The bank's total assets are projected to grow to 4,235,199 million yuan by 2025E, with a loan growth rate of 14% [10] Valuation Metrics - The target price for Jiangsu Bank is set at 12.62 yuan per share, with a current price of 10.13 yuan [5] - The price-to-earnings (P/E) ratio for 2025E is projected at 5.67, while the price-to-book (P/B) ratio is expected to be 0.72 [8][10] - The bank's average return on equity (ROE) is forecasted to be 13.31% in 2025E [10]